Cardinal Health, Inc. (CAH)

$122.63

+0.19

(+0.16%)▲

Market is closed - opens 8 PM, 29 Nov 2024

Performance

  • $121.60
    $123.45
    $122.63
    downward going graph

    0.84%

    Downside

    Day's Volatility :1.5%

    Upside

    0.66%

    downward going graph
  • $93.17
    $126.14
    $122.63
    downward going graph

    24.02%

    Downside

    52 Weeks Volatility :26.13%

    Upside

    2.78%

    downward going graph

Returns

PeriodCardinal Health, Inc.Sector (Health Care)S&P500
3 Months
10.44%
-5.7%
7.3%
6 Months
29.42%
3.0%
13.1%
1 Year
15.51%
13.4%
31.7%
3 Years
158.33%
11.4%
30.6%

Highlights

Market Capitalization
29.6B
Book Value
-$13.54
Dividend Share
2.012
Dividend Yield
1.65%
Earnings Per Share (EPS)
5.2
PE Ratio
23.55
PEG Ratio
1.03
Wall Street Target Price
124.483
Profit Margin
0.57%
Operating Margin TTM
1.05%
Return On Assets TTM
3.18%
Return On Equity TTM
0.0%
Revenue TTM
224.5B
Revenue Per Share TTM
921.78
Quarterly Revenue Growth YOY
-4.3%
Gross Profit TTM
6.5B
EBITDA
2.9B
Diluted Eps TTM
5.2
Quarterly Earnings Growth YOY
48.14
EPS Estimate Current Year
7.36
EPS Estimate Next Year
7.53
EPS Estimate Current Quarter
1.62
EPS Estimate Next Quarter
1.81

Analyst Recommendation

Hold
    45%Buy
    50%Hold
    4%Sell
Based on 22 Wall street analysts offering stock ratings for Cardinal Health, Inc.(by analysts ranked 0 to 5 stars)
Based on 22 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
8
Hold
11
11
12
Sell
1
1
1

Analyst Forecast

What analysts predicted

Upside of 1.51%

Current $122.63
Target $124.48

Company Financials

FY19Y/Y Change
Revenue
145.5B
↑ 6.38%
Net Income
1.4B
↑ 432.42%
Net Profit Margin
0.94%
↑ 0.75%
FY20Y/Y Change
Revenue
152.9B
↑ 5.08%
Net Income
-3.7B
↓ 370.95%
Net Profit Margin
-2.41%
↓ 3.35%
FY21Y/Y Change
Revenue
162.5B
↑ 6.24%
Net Income
611.0M
↓ 116.54%
Net Profit Margin
0.38%
↑ 2.79%
FY22Y/Y Change
Revenue
181.4B
↑ 11.63%
Net Income
-932.0M
↓ 252.54%
Net Profit Margin
-0.51%
↓ 0.89%
FY23Y/Y Change
Revenue
205.0B
↑ 13.04%
Net Income
261.0M
↓ 128.0%
Net Profit Margin
0.13%
↑ 0.64%
FY24Y/Y Change
Revenue
226.8B
↑ 10.64%
Net Income
852.0M
↑ 226.44%
Net Profit Margin
0.38%
↑ 0.25%
Q2 FY23Q/Q Change
Revenue
53.5B
↑ 5.87%
Net Income
-64.0M
↓ 118.55%
Net Profit Margin
-0.12%
↓ 0.8%
Q3 FY23Q/Q Change
Revenue
54.8B
↑ 2.45%
Net Income
5.0M
↓ 107.81%
Net Profit Margin
0.01%
↑ 0.13%
Q4 FY23Q/Q Change
Revenue
57.4B
↑ 4.9%
Net Income
353.0M
↑ 6960.0%
Net Profit Margin
0.61%
↑ 0.6%
Q1 FY24Q/Q Change
Revenue
54.9B
↓ 4.41%
Net Income
258.0M
↓ 26.91%
Net Profit Margin
0.47%
↓ 0.14%
Q2 FY24Q/Q Change
Revenue
59.9B
↑ 9.03%
Net Income
236.0M
↓ 8.53%
Net Profit Margin
0.39%
↓ 0.08%
Q3 FY24Q/Q Change
Revenue
52.3B
↓ 12.68%
Net Income
416.0M
↑ 76.27%
Net Profit Margin
0.8%
↑ 0.41%
FY19Y/Y Change
Total Assets
41.0B
↑ 2.53%
Total Liabilities
34.6B
↑ 2.19%
FY20Y/Y Change
Total Assets
40.8B
↓ 0.48%
Total Liabilities
39.0B
↑ 12.53%
FY21Y/Y Change
Total Assets
44.5B
↑ 9.04%
Total Liabilities
42.7B
↑ 9.46%
FY22Y/Y Change
Total Assets
43.9B
↓ 1.29%
Total Liabilities
44.6B
↑ 4.51%
FY23Y/Y Change
Total Assets
43.4B
↓ 1.05%
Total Liabilities
46.3B
↑ 3.78%
FY24Y/Y Change
Total Assets
45.1B
↑ 3.92%
Total Liabilities
48.3B
↑ 4.46%
Q2 FY23Q/Q Change
Total Assets
43.4B
↑ 0.09%
Total Liabilities
46.3B
↑ 1.48%
Q3 FY23Q/Q Change
Total Assets
43.7B
↑ 0.67%
Total Liabilities
47.2B
↑ 2.01%
Q4 FY23Q/Q Change
Total Assets
46.6B
↑ 6.55%
Total Liabilities
50.0B
↑ 5.97%
Q1 FY24Q/Q Change
Total Assets
45.9B
↓ 1.49%
Total Liabilities
49.1B
↓ 1.76%
Q2 FY24Q/Q Change
Total Assets
45.1B
↓ 1.65%
Total Liabilities
48.3B
↓ 1.65%
Q3 FY24Q/Q Change
Total Assets
43.1B
↓ 4.57%
Total Liabilities
46.3B
↓ 4.13%
FY19Y/Y Change
Operating Cash Flow
2.7B
↓ 1.66%
Investing Cash Flow
338.0M
↓ 106.03%
Financing Cash Flow
-2.3B
↑ 0.75%
FY20Y/Y Change
Operating Cash Flow
2.0B
↓ 27.99%
Investing Cash Flow
493.0M
↑ 45.86%
Financing Cash Flow
-2.2B
↓ 4.06%
FY21Y/Y Change
Operating Cash Flow
2.4B
↑ 23.93%
Investing Cash Flow
-378.0M
↓ 176.67%
Financing Cash Flow
-1.3B
↓ 40.14%
FY22Y/Y Change
Operating Cash Flow
3.1B
↑ 28.53%
Investing Cash Flow
567.0M
↓ 250.0%
Financing Cash Flow
-2.5B
↑ 87.02%
FY23Y/Y Change
Operating Cash Flow
2.8B
↓ 9.06%
Investing Cash Flow
-454.0M
↓ 180.07%
Financing Cash Flow
-3.1B
↑ 23.87%
Q2 FY23Q/Q Change
Operating Cash Flow
858.0M
↓ 36.96%
Investing Cash Flow
-206.0M
↑ 126.37%
Financing Cash Flow
-592.0M
↓ 36.62%
Q3 FY23Q/Q Change
Operating Cash Flow
545.0M
↓ 36.48%
Investing Cash Flow
-63.0M
↓ 69.42%
Financing Cash Flow
-666.0M
↑ 12.5%

Technicals Summary

Sell

Neutral

Buy

Cardinal Health, Inc. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Cardinal Health, Inc.
Cardinal Health, Inc.
10.61%
29.42%
15.51%
158.33%
122.84%
Cencora Inc
Cencora Inc
6.9%
15.48%
24.04%
45.7%
120.2%
Mckesson Corporation
Mckesson Corporation
23.07%
14.04%
35.7%
180.55%
333.06%
Henry Schein, Inc.
Henry Schein, Inc.
9.21%
9.15%
15.21%
5.27%
12.71%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Cardinal Health, Inc.
Cardinal Health, Inc.
23.55
23.55
1.03
7.36
0.0
0.03
0.02
-13.54
Cencora Inc
Cencora Inc
32.67
32.67
1.27
13.65
2.09
0.03
0.01
4.01
Mckesson Corporation
Mckesson Corporation
32.37
32.37
1.29
27.59
0.0
0.04
0.0
-23.77
Henry Schein, Inc.
Henry Schein, Inc.
31.67
31.67
1.78
4.77
0.06
0.04
NA
27.99
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Cardinal Health, Inc.
Cardinal Health, Inc.
Hold
$29.6B
122.84%
23.55
0.57%
Cencora Inc
Cencora Inc
Buy
$48.2B
120.2%
32.67
0.51%
Mckesson Corporation
Mckesson Corporation
Buy
$79.3B
333.06%
32.37
0.77%
Henry Schein, Inc.
Henry Schein, Inc.
Hold
$9.6B
12.71%
31.67
2.51%

Insights on Cardinal Health, Inc.

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 59.86B → 52.27B (in $), with an average decrease of 12.7% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, 236.0M → 416.0M (in $), with an average increase of 43.3% per quarter

  • Vs MCK

    In the last 1 year, Mckesson Corporation has given 35.7% return, outperforming this stock by 20.2%

  • Vs MCK

    In the last 3 years, Mckesson Corporation has given 182.6% return, outperforming this stock by 25.0%

Institutional Holdings

  • BlackRock Inc

    12.73%

  • Vanguard Group Inc

    12.72%

  • State Street Corp

    5.60%

  • Morgan Stanley - Brokerage Accounts

    3.93%

  • Geode Capital Management, LLC

    2.38%

  • FMR Inc

    1.79%

Corporate Announcements

  • Cardinal Health, Inc. Dividends March,2025

    In the quarter ending March,2025. Cardinal Health, Inc. has declared dividend of $0.51

    Read More

Company Information

cardinal health, inc. (nyse: cah), is a global integrated healthcare services and products company, providing customized solutions for hospital systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide. the company provides clinically-proven medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. cardinal health connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination and better patient management. backed by nearly 100 years of experience, with more than 37,000 employees in nearly 60 countries, cardinal health ranks among the top 25 on the fortune 500. for more information, visit cardinalhealth.com, follow @cardinalhealth on twitter.

Organization
Cardinal Health, Inc.
Employees
47922
CEO
Mr. Stephen M. Mason
Industry
Wholesale Trade

FAQs